A possible role for dihydrodiol dehydrogenase in the formation of benzo[a]pyrene-DNA adducts in lung cancer cells and tumor tissues

Environmental and Molecular Mutagenesis

Volumn 48, Issue 1, 2007, Pages 14-21

  Cheng, Ya Wen ^a   Tsai, Horng Jyh ^a   Wu, Jeng Yuan ^a,b   Hsu, Yi Feng ^a   Chen, Chih Yi ^c   Hao, Nina Jyu ^a   Lee, Huai ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Dihydrodiol dehydrogenose; DNA damage; Nonsmall cell lung cancer

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450 1A1; DIHYDRODIOL DEHYDROGENASE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ADDUCT; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; PROTEIN EXPRESSION;

BENZO(A)PYRENE; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DNA ADDUCTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LUNG NEOPLASMS; MALE; OXIDOREDUCTASES; RNA, SMALL INTERFERING; TRANSFECTION;

NICOTIANA TABACUM;

EID: 33846894513     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20270     Document Type: Article

References (34)

1. Ansell PJ, Lo SC, Newton LG, Espinosa-Nicholas C, Zhang DD, Liu JH, Hannink M, Lubahn DB. 2005. Repression of cancer protective genes by 17β-estradiol: Ligand-dependent interaction between human Nrf2 and estrogen receptor α. Mol Cell Endocrinol 243:27-34.
2. Bain C, Feskanich D, Speizer FE, Thun M, Hertzmark E, Rosner BA, Colditz GA. 2004. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 96:826-834.
3. Blot WJ, McLaughlin JK. 2004. Are women more susceptible to lung cancer? J Natl Cancer Inst 96:812-813.
4. Bosken CH, Wei Q, Amos CI, Spitz MR. 2002. An analysis of DNA repair as a determinant of survival in patients with non-small cell lung cancer. J Natl Cancer Inst 94:1091-1099.
5. Bostrom CE, Gerde P, Hanberg A, Jemstrom B, Johansson C, Kyrklund T, Rannug A.Tomqvist M, Victorin K, Westerholm R. 2002. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Eviron Health Perspect 110:451-488.
6. Burczynski ME, Penning TM. 2000. Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor. Cancer Res 60:908-915.
7. Chang JT. 2005. An economic and efficient method of RNAi vector constructions. Anal Biochem 334:199-200.
8. Chen CY, Hsu CP, Hsu NY, Shih CS, Lin TY, Chow KC. 2002. Expression dihydrodiol dehydrogenase resected stage non small cell lung cancer. Oncol Rep 9:515-519.
9. Cheng YW, Chen CY, Chen CP, Huang KH, Lin TS, Wu MH, Lee H. 2000. DNA adduct level in lung tissue may act as a risk biomarker of lung cancer. Eur J Cancer 36:1381-1388.
10. Cheng YW, Hsie LL, Lin P, Chen CP, Chen CY, Lin TS, Su JM, Lee H. 2001. Gender difference in DNA adduct levels among non-smoking lung cancer patients. Environ Mol Mutagen 37:304-310.
11. Chemg SH, Hsu SL, Yang JL, Yu CT, Lee H. 2006. Suppressive effect of I-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells. Toxicol Lett 161:236-243.
12. Ciaccio PJ, Walsh ES, Tew KD. 1996. Promoter analysis of a human dihydrodiol dehydrogenase. Biochem Biophys Res Commun 228:524-529.
13. Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS, Wang LS, Tsai CM. 2001. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 61:2727-2731.
14. Jenks S. 1996. Gender may render women at risk for lung cancer. J Natl Cancer Inst 88:139-140.
15. Jiang H, Shen YM, Quinn AM, Penning TM. 2005. Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (±)-7,8-dihydroxy-7,8-dihidro-benzo[a]-pyrene in human bronchoalveolar cell extracts. Chem Res Toxicol 18:365-374.
16. Lai JC, Cheng YW, Chiou HL, Wu MF, Chen CY, Lee H. 2005. Gender difference in estrogen receptor α promoter hypermethylation and its prognostic value in non-small cell lung cancer. Int J Cancer 117:974-980.
17. Miao W, Hu L, Scrivens J, Batist G. 2005. Transcriptional regulation of NF-E2 p45-related factors (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway. J Biol Chem 280:20340-20348.
18. Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A. 1999. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59:3317-3320.
19. Montano MM, Deng H, Liu M, Sun X, Singal R. 2004. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 23:2442-2253.
20. Mumford JL, Williams K, Wilcosky TC, Everson EB, Young TL, Santella RM. 1996. A sensitive color ELISA for detecting polycyclic aromatic hydrocarbon-DNA adducts in human tissues. Mutat Res 359:171-177.
21. Olak J, Colson Y. 2004. Gender difference in lung cancer: Have we really come a long way, baby? J Thorac Cardiovasc Surg 128:346-351.
22. Osann KE, Anton-Culver H, Kurosaki T, Taylor T. 1993. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 54:44-48.
23. Palackal NT, Lee SH, Harvey RG, Blair IA, Penning TM. 2002. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J Biol Chem 277:24799-24808.
24. Penning TM, Burczynski ME, Hung CF, McCoull KD, Palackal NT, Tsurud LS. 1999. Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activatoin: Generation of reactive and redox active o-quinones. Chem Res Toxicol 12:1-18.
25. Ryberg D, Hewer A, Phillips DH, Haugen A. 1994. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 54:5801-5803.
26. Samanta SK, Singh OV, Jain RK. 2002. Polycyclic aromatic hydrocarbons: Environmental pollution and bioremediation. Trends Biotechnol 20:243-248.
27. Santella RM, Weston A, Perera FP, Trivers GT, Harris CC, Young TL, Nguyen D, Lee BM, Poirier MC. 1998. Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-dioloepoxide-I-modified DNA. Carcinogenesis 9:1265-1269.
28. Shiraishi H, Matsuura K, Kume T, Hara A. 1999. Expression of mRNAs for dihydrodiol dehydrogenase isoforms in human tissues. Adv Exp Med Biol 463:539-544.
29. Siggfried JM. 2001. Women and lung cancer: Does oestrogen play a role? Lancet Oncol 2:506-513.
30. Tang DW, Chang KW, Chi CW, Liu TY. 2004. Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase. Toxicol Lett 152:235-243.
31. Thomas L, Doyle A, Edelman MJ. 2005. Lung cancer in women: Emerging differences in epidemiology, biology, and therapy. Chest 128:370-381.
32. Venkatachalam S, Denissenko M, Wani AA. 1995. DNA repair in human cells: Quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays. Carcinogenesis 16:2029-2036.
33. Xue W, Warshawsky D. 2005. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol Appl Pharmacol 206:73-93.
34. Zang EA, Wynder EL. 1996. Differences in lung cancer risk between men and women: Examination of the evidence. J Natl Cancer Inst 88:183-192.